Abaloparatide

InterventionApproved 20172 papersPubChem 76943386

Trials

9

Approved

FDA · Tymlos
28 Apr 2017 · Osteoporosis, fractures
EMA · Eladynos
12 Dec 2022 · Osteoporosis, Postmenopausal, Osteoporosis

Repurposing

Bone fracture
Phase 3 · Results posted · 4 trials
Osteoporotic fractures
Phase 3 · Results posted · 1 trial
Pain
Phase 2 · Active, not recruiting · 1 trial
Myelodysplastic syndrome
Phase 1 · Completed · 1 trial

In trials

Metabolic bone disease
Phase 3 · Results posted · 3 trials

Trial sponsors

Radius Health
Company3 trialsPhase 32,714 people
Hospital for Special Surgery, New York
1 trialPhase 296 people
State University of New York - Downstate Medical Center
1 trialPhase 260 people
David Lunardini
1 trialPhase 222 people
University of Rochester
1 trialPhase 120 people

Latest

2

Calcified Tissue InternationalReview18 Sep

Anti-osteoporotic Pharmacotherapy and Muscle Outcomes in Osteosarcopenia: a Source-Verified Translational Evidence Map

Osteosarcopenia

Journal of Clinical MedicineReview27 Aug

Preventing Hip (Proximal Femoral) Fractures: An Evidence-Based Review for Clinicians

ENDO 2025 AbstractAnimals23 Oct

MON-740 Abaloparatide Increases Bone Marrow Stromal Cells And Decreases Features Of Hematopoietic Aging In Old Male Mice